Sodium Bicarbonate 10 GR (650 MG)

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Sodium Bicarbonate 10 GR (650 MG)
Generic name: SODIUM BICARBONATE
Manufacturer: Advanced Rx LLC
Product type: HUMAN OTC DRUG
SPL set ID: 634e8d52-6d04-42f9-98f6-2634473b5dfd
SPL ID: 3d912fde-5c7a-e74c-e063-6394a90a6e1f
Version: 1
Effective date: 2025-09-01
Source export date: 2026-09-28
Source partition: 13
Source file: https://download.open.fda.gov/drug/label/drug-label-0013-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/e78bf8aa9f90ab13e640d254dfbd4fe5bfeca4995ec5f9d51bce3356e249cab7/drug-label-0013-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:37:44

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M001	openfda.application_number
brand name		Sodium Bicarbonate 10 GR (650 MG)	openfda.brand_name
generic name		SODIUM BICARBONATE	openfda.generic_name
manufacturer name		Advanced Rx LLC	openfda.manufacturer_name
ndc	package	80513-611-02	openfda.package_ndc
ndc	product	80513-611	openfda.product_ndc
ndc11	package	80513061102	derived:openfda.package_ndc
rxcui		198861	openfda.rxcui
spl id		3d912fde-5c7a-e74c-e063-6394a90a6e1f	id
spl set id		634e8d52-6d04-42f9-98f6-2634473b5dfd	set_id
unii		8MDF5V39QO	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS Do not take more than 24 tablets for adults up to 60 years of age (or 12 tablets for adults 60 years of age and older) in a 24 hour period nor use maximum dosage for more than 2 weeks, except under the advice and supervision of a physician.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.